In this symposium, an expert panel will discuss how sequencing and omics technologies enable unprecedented exploration of health and disease, from genetic disorders to cancer.
By studying the genomes of more than 24,000 individuals, researchers discovered rare genetic mutations that may shed light on mechanisms underlying schizophrenia.